Jun‐Cheng Su
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis
Papers in
-
- Bioactive Natural Diterpenoids Research 7
- Natural product bioactivities and synthesis 5
-
- Quinazolinone synthesis and applications 7
- Catalytic C–H Functionalization Methods 6
- Co-authors
- Wen‐Cai Ye (10 shared papers)Xiao‐Jun Huang (9 shared papers)Ying Wang (9 shared papers)Yao-Lan Li (5 shared papers)Ren‐Wang Jiang (3 shared papers)Wei Tang (4 shared papers)Hou‐Wen Lin (3 shared papers)Luo-Sheng Wan (8 shared papers)
In The Last Decade
Jun‐Cheng Su
46 papers receiving 640 citations
Peers
Comparison fields: 5 of 72
- Toxicology 45
- Pharmacology 179
- Biotechnology 80
- Pharmacology 56
- Drug Discovery 1
Countries citing papers authored by Jun‐Cheng Su
This map shows the geographic impact of Jun‐Cheng Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun‐Cheng Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun‐Cheng Su more than expected).
Fields of papers citing papers by Jun‐Cheng Su
This network shows the impact of papers produced by Jun‐Cheng Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun‐Cheng Su. The network helps show where Jun‐Cheng Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun‐Cheng Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 52 | |
| 2 | 2019 | 52 | |
| 3 | 2019 | 47 | |
| 4 | 2018 | 46 | |
| 5 | 2021 | 32 | |
| 6 | 2020 | 31 | |
| 7 | 2021 | 28 | |
| 8 | 2021 | 27 | |
| 9 | 2020 | 23 | |
| 10 | 2021 | 21 | |
| 11 | 2018 | 21 | |
| 12 | 2021 | 20 | |
| 13 | 2024 | 19 | |
| 14 | 2021 | 18 | |
| 15 | 2023 | 17 | |
| 16 | 2021 | 15 | |
| 17 | 2017 | 15 | |
| 18 | 2020 | 14 | |
| 19 | 2022 | 14 | |
| 20 | 2022 | 14 |
About Jun‐Cheng Su
Jun‐Cheng Su is a scholar working on Molecular Biology, Organic Chemistry, Plant Science, Pharmacology and Pharmacology, having authored 51 papers that have together received 645 indexed citations. Recurring topics across this work include Phytochemistry and Biological Activities (8 papers), Bioactive Natural Diterpenoids Research (7 papers), Quinazolinone synthesis and applications (7 papers), Natural Compound Pharmacology Studies (7 papers), Synthesis of Organic Compounds (6 papers), Catalytic C–H Functionalization Methods (6 papers), Microbial Natural Products and Biosynthesis (6 papers) and Natural product bioactivities and synthesis (5 papers). The work is most often cited by research in Toxicology (45 citations), Pharmacology (179 citations), Biotechnology (80 citations), Pharmacology (56 citations) and Drug Discovery (1 citation). Jun‐Cheng Su has collaborated with scholars based in China, Thailand and Australia. Frequent co-authors include Wen‐Cai Ye, Xiao‐Jun Huang, Ying Wang, Yao-Lan Li, Ren‐Wang Jiang, Wei Tang, Hou‐Wen Lin, Luo-Sheng Wan, Qiao‐Yun Song and Man‐Mei Li. Their work appears in journals such as Bioorganic Chemistry, Organic Letters, Journal of Natural Products, Fitoterapia and The Journal of Organic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.